PT1149910E - Composicao farmaceutica contra os tumores e as infeccoes por papilomavirus - Google Patents

Composicao farmaceutica contra os tumores e as infeccoes por papilomavirus

Info

Publication number
PT1149910E
PT1149910E PT01109013T PT01109013T PT1149910E PT 1149910 E PT1149910 E PT 1149910E PT 01109013 T PT01109013 T PT 01109013T PT 01109013 T PT01109013 T PT 01109013T PT 1149910 E PT1149910 E PT 1149910E
Authority
PT
Portugal
Prior art keywords
infections
papilomavirus
pharmaceutical composition
composition against
against tumors
Prior art date
Application number
PT01109013T
Other languages
English (en)
Portuguese (pt)
Inventor
Nadine Bizouarne
Marie-Paule Kieny
Jean-Marc Balloul
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9494633&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1149910(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Transgene Sa filed Critical Transgene Sa
Publication of PT1149910E publication Critical patent/PT1149910E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
PT01109013T 1996-07-30 1997-07-29 Composicao farmaceutica contra os tumores e as infeccoes por papilomavirus PT1149910E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9609584A FR2751879B1 (fr) 1996-07-30 1996-07-30 Composition pharmaceutique contre les tumeurs et infections a papillomavirus

Publications (1)

Publication Number Publication Date
PT1149910E true PT1149910E (pt) 2004-09-30

Family

ID=9494633

Family Applications (2)

Application Number Title Priority Date Filing Date
PT01109013T PT1149910E (pt) 1996-07-30 1997-07-29 Composicao farmaceutica contra os tumores e as infeccoes por papilomavirus
PT97935646T PT862634E (pt) 1996-07-30 1997-07-29 Composicao farmaceutica contra os tumores e infeccoes de papilomavirus

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT97935646T PT862634E (pt) 1996-07-30 1997-07-29 Composicao farmaceutica contra os tumores e infeccoes de papilomavirus

Country Status (12)

Country Link
EP (2) EP1149910B1 (enExample)
JP (2) JP4070815B2 (enExample)
AT (2) ATE265535T1 (enExample)
AU (1) AU736720B2 (enExample)
CA (1) CA2234263C (enExample)
DE (2) DE69706825T3 (enExample)
DK (2) DK0862634T4 (enExample)
ES (2) ES2215805T3 (enExample)
FR (1) FR2751879B1 (enExample)
HK (1) HK1043809B (enExample)
PT (2) PT1149910E (enExample)
WO (1) WO1998004705A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7182947B2 (en) 1998-02-20 2007-02-27 Medigene Ag Papillomavirus truncated L1 protein and fusion protein constructs
US7494658B2 (en) 1998-02-20 2009-02-24 Medigene Ag Papilloma virus truncated L1 protein and fusion protein constructs
CA2229955C (en) 1998-02-20 2003-12-09 Medigene Gmbh Papilloma virus capsomere vaccine formulations and methods of use
US20020039584A1 (en) 1998-02-20 2002-04-04 Medigene Ag Papilloma virus capsomere vaccine formulations and methods of use
US6926897B1 (en) 1998-03-24 2005-08-09 Medigene Aktiengesellschaft Medicament for the avoidance or treatment of papillomavirus-specific tumour
CA2335506A1 (en) * 1998-06-26 2000-01-06 Aventis Pasteur Mucosal targeting immunisation
DK2029756T3 (en) 2006-06-20 2017-02-13 Transgene Sa PROCEDURE FOR PREPARING POXVIRA AND POXVIRUS COMPOSITIONS
EP2382474B1 (en) 2009-01-20 2015-03-04 Transgene SA Soluble icam-1 as biomarker for prediction of therapeutic response
NZ595290A (en) 2009-03-24 2012-09-28 Transgene Sa Biomarker for monitoring patients
WO2010119003A1 (en) 2009-04-17 2010-10-21 Transgene Sa Biomarker for monitoring patients
EP2429580A1 (en) 2009-05-12 2012-03-21 Transgene SA Method for orthopoxvirus production and purification
CA2767458A1 (en) 2009-07-10 2011-01-13 Bruce Acres Biomarker for selecting patients and related methods
AU2010275764A1 (en) 2009-07-21 2012-03-15 Transgene Sa Enzymatic composition for the digestion of chicken embryos
TWI690322B (zh) 2012-10-02 2020-04-11 法商傳斯堅公司 含病毒的調配物及其使用
CN107206063B (zh) 2014-12-01 2021-09-28 特兰斯吉恩股份有限公司 稳定的液体痘苗病毒制剂
FR3042121A1 (fr) * 2015-10-08 2017-04-14 Jean-Marc Limacher Composition anti-tumorale
KR20200003921A (ko) 2017-05-15 2020-01-10 얀센 백신스 앤드 프리벤션 비.브이. 안정한 바이러스-함유 조성물
KR102658198B1 (ko) 2017-05-15 2024-04-16 얀센 백신스 앤드 프리벤션 비.브이. 안정한 바이러스 함유 조성물
US12150988B2 (en) 2018-09-06 2024-11-26 Bavarian Nordic A/S Storage improved poxvirus compositions
US20230114464A1 (en) 2020-03-12 2023-04-13 Bavarian Nordic A/S Conditions Improving Poxvirus Stability

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2643817B1 (fr) * 1989-03-06 1993-12-17 Transgene Sa Composition pharmaceutique, utile a titre preventif ou curatif contre les tumeurs induites par les papillomavirus
CA2038581A1 (en) † 1990-03-20 1991-09-21 Martin Muller Seroreactive epitopes of human papillomavirus (hpv) 16 proteins
GB9113809D0 (en) * 1991-06-26 1991-08-14 Cancer Res Campaign Tech Papillomavirus l2 protein
DK1359156T3 (da) * 1991-07-19 2007-04-10 Univ Queensland Vaccine mod humanpapillomavirus
US5618536A (en) * 1992-09-03 1997-04-08 The United States Of America As Represented By The Department Of Health And Human Services Chimeric papillomavirus-like particles
GB9306731D0 (en) * 1993-03-31 1993-05-26 Cancer Res Campaign Tech Vaccines
IL113817A (en) * 1994-06-30 2001-03-19 Merck & Co Inc Polynucleotide vaccne for papillomavirus
EP0789774A2 (en) * 1994-10-03 1997-08-20 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Enhanced immune response by introduction of cytokine gene and/or costimulatory molecule b7 gene in a recombinant virus expressing system
GB9505784D0 (en) * 1995-03-22 1995-05-10 Lynxvale Ltd Anti-tumour treatment
FR2749323B1 (fr) * 1996-06-04 1998-07-10 Pasteur Merieux Serums Vacc Pseudo-particules virales utiles en tant que vecteur de delivrance d'acide nucleique

Also Published As

Publication number Publication date
CA2234263C (fr) 2009-10-13
EP0862634B1 (fr) 2001-09-19
EP1149910A1 (fr) 2001-10-31
DE69728914T2 (de) 2005-04-07
DK0862634T4 (da) 2006-05-08
ES2163795T3 (es) 2002-02-01
JP2000500662A (ja) 2000-01-25
EP1149910B1 (fr) 2004-04-28
ES2163795T5 (es) 2006-07-16
CA2234263A1 (fr) 1998-02-05
DE69706825D1 (de) 2001-10-25
FR2751879A1 (fr) 1998-02-06
JP4070815B2 (ja) 2008-04-02
WO1998004705A1 (fr) 1998-02-05
DK1149910T3 (da) 2004-08-02
EP0862634B2 (fr) 2006-03-01
ES2215805T3 (es) 2004-10-16
FR2751879B1 (fr) 1998-10-30
AU736720B2 (en) 2001-08-02
PT862634E (pt) 2002-03-28
HK1043809A1 (en) 2002-09-27
DE69706825T3 (de) 2006-08-24
ATE265535T1 (de) 2004-05-15
JP4198735B2 (ja) 2008-12-17
DK0862634T3 (da) 2002-01-21
ATE205881T1 (de) 2001-10-15
DE69728914D1 (de) 2004-06-03
EP0862634A1 (fr) 1998-09-09
JP2007254474A (ja) 2007-10-04
AU3855297A (en) 1998-02-20
DE69706825T2 (de) 2002-05-02
HK1043809B (zh) 2004-12-03

Similar Documents

Publication Publication Date Title
PT1149910E (pt) Composicao farmaceutica contra os tumores e as infeccoes por papilomavirus
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
ATE525387T1 (de) Rekombinante p53 x adenovirus-konstrukte methoden und zusammensetzungen
GR3036714T3 (en) Fungicidal trifluorophenyl-triazolopyrimidines
DE69401204D1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
DE59410380D1 (de) Endosomolytisch wirksame partikel
RU95106674A (ru) Полиеновые соединения, фармацевтическая и косметическая композиция на их основе
KR860005636A (ko) 활성성분으로 스페르구알린(Spergualin)을 함유하는 주사제 조성물과 그 제조방법.
SE9201628D0 (sv) Pharmaceutical composition
UA50808C2 (uk) Композиція для лікування респіраторного дистрес-синдрому дорослих або респіраторного дистрес-синдрому новонароджених
KR0180256B1 (en) Bpc peptides, their preparation and use
ZA923940B (en) Substituted diaminophthalimides and analogues
DK0842165T3 (da) Thiazolidin-4-carboxylsyrederivater som cytobeskyttende midler
RU95106653A (ru) Производные 2-имидазолин-5-онов и 2-имидазолин-5-тионов и фунгицидные композиции на их основе
ATE92542T1 (de) Azeotropaehnliche zusammensetzungen von 1,1dichlor-2,2,2-trifluoraethan und 1,1-dochlor-1fluor|than.
AU1192397A (en) Substituted thiazolines and their use for controlling animal pests
DE69619530D1 (de) Zyklische somatostatinanaloge mit wachstumhormon inhibierender aktivität
AU6722498A (en) Disubstituted biphenyloxazolines
KR970702880A (ko) 신규한 펩티드 활성 물질 및 그의 제조 방법(New Peptide Active Substance And Production Thereof)
DK0713485T3 (da) Thiocarbamoylforbindelser som mikrobicider
IT8622348A0 (it) 2-bromo,1',2',-dicloro-perfluoro dietil-etere e procedimento per lasua preparazione.
EP0153755A3 (en) Compounds for treating hypertension
IT1197892B (it) Composizioni farmaceutiche ad attivita' cicatrizzante
RU94019328A (ru) α- ГЕТЕРОАРИЛОКСИМЕТИЛКЕТОНЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ИНГИБИРУЮЩАЯ ИНТЕРЛЕЙКИН-1 - β -ПРОТЕАЗУ